Many analysts are skeptical that a turnaround in Lululemon’s U.S. product offerings will be swift enough to warrant conviction on the stock.
Communicating your story to the Street
Many analysts are skeptical that a turnaround in Lululemon’s U.S. product offerings will be swift enough to warrant conviction on the stock.